Courtesy of The Times
In early January, Methodist Hospitals announced its purchase of new imaging technology for its Cardiovascular Institute. Methodists' cardiologists are the first in the state of Indiana to utilize the cutting-edge technology called Optical Coherence Tomography (OCT) to aid in the diagnosis and treatment of cardiovascular disease.
The C7-XRTM OCT Intravascular Imaging System developed by LightLab Imaging Inc, and recently acquired by St. Jude Medical Inc, is a new imaging technology platform that aids physicians in the diagnosis and treatment of cardiovascular disease. The system allows cardiologists to see inside human heart arteries using a high resolution camera and a light source. This new equipment goes beyond older coronary imaging technologies- such as fluoroscopy and intravascular ultrasound (IVUS) - offering cardiologists an assessment method with enhanced clarity for their patients with coronary artery disease.
Says Nazzal Obaid, M.D., Medical Director of Methodist Hospitals' Cardiovascular Institute, "This technology is practice-changing: with it we are able to see inside a patient's blood vessel in a way never possible before, allowing us to more quickly and precisely identify coronary disease and guide its treatment."
According to Dr. Obaid, the imaging capabilities of the C7 -XR system assist the cardiologist in stent selection and placement by providing precise measurements of lesion dimensions and coronary artery size and structure. The system also provides the cardiologist with information about the stent position and opening to help reduce the risk of coronary vessel renarrowing and to guide follow-up treatment.
"Methodist Hospitals is proud to be the first in Indiana to use the advanced OCT technology," said Ian McFadden, President and CEO. "In 2010, Methodist Hospital has invested more than $36 million in technology, equipment, and programs to enhance patient care. This purchase is the latest example of our commitment to deliver the highest quality patient care."